DC Roundtable 2015 Speakers
IP Partner & Nanotech Team Member, Foley & Lardner LLP
Stephen (Steve) B. Maebius is a partner and intellectual property lawyer with Foley & Lardner LLP. He has led teams within Foley handling a variety of different kinds of IP work, including IP due diligence reviews, infringement and validity opinions, international portfolio management, licensing, litigation with parallel inter partes reviews, reexaminations and interferences, and pharmaceutical patent term extensions. Two IP transactions in which Mr. Maebius has participated were awarded “Deal of Distinction” status by the Licensing Executives Society. He is a former member of the firm’s Management Committee and former chair of the Intellectual Property Department. Prior to becoming a lawyer, he was a patent examiner in the Biotechnology Group of the U.S. Patent & Trademark Office.
Mr. Phillips is internationally credited with being very instrumental in launching instant messaging, the PDA, Cable Modem, PCS, Fixed Cellular, Time Magazine’s Medical Invention of the Year – the VeinViewer, and iPix, at the time, the world’s largest provider of digital imaging infrastructure for the internet, in such areas as virtual tours, telepresence, online real estate, hospitality, and security. Throughout his business career, Jim has held numerous prominent positions and founded and co-founded many successful corporations while introducing many products used by millions worldwide.
President & CEO, Nanophase
Beginning in 2009, Mr. Jankowski has lead Nanophase in a targeted strategic expansion in to several new markets, working directly with commercial end-users, in order to best exploit the Company’s technical and market advantages.
In addition to its legacy book of business, Nanophase has currently focused its business and technical development on four key applications areas:
- Personal Care
- Surface Finishing
- Alkaline Batteries
- Solar Control
He believes that this high degree of focus will best position Nanophase for significant near- and mid-term growth.
In addition to serving on the board of directors of Nanophase, Mr. Jankowski serves on a series of commercially-focused and non-profit boards. These currently include; the Northern Illinois Research Foundation, the NanoBusiness Commercialization Association, and Thrive Chicago. Past service has included; the TechAmerica Midwest Board, the Romeoville Economic Development Commission, and the Joliet Montessori School.
Chairman & CEO, PEN Inc
CEO, OCSiAl LLC
Dr. Michael A. Meador
Director, National Nanotechnology Coordination Office (NNCO)
Dr. Meador, chair of NASA’s Nanotechnology Roadmap Team, was instrumental in developing the NASA-wide Nanotechnology Project, and has been responsible for project planning and advocacy, overseeing technical progress, developing external partnerships to advance and transfer technology, coordinating with other nanotechnology related activities within NASA, and interacting with program and senior agency management. He has also played a key role in representing NASA in the NNI’s interagency activities, including co-chairing its Nanomanufacturing, Industry Liaison, and Innovation Working Group.
Executive Director – NanoBusiness Commercialization Association
Dr. Ybet Villacorta
Intellectual Property Department Chair, Washington DC Office, Foley & Lardner LLP
Dr. Gilberto M. (Ybet) Villacorta is a partner and intellectual property lawyer with Foley & Lardner LLP where he focuses on establishing, exploiting and enforcing intellectual property rights in marketable products, systems and servicesSM. He assists technologically diverse clients worldwide with their intellectual property and business transactions needs. These needs may include the planning, development and maintenance of patent and trademark portfolios; licensing, marketing, product development negotiations and the preparation of the resulting agreements; due diligence investigations in connection with mergers, acquisitions, formation of joint ventures and financing; patentability, registrability, peer review, market assessment, validity and infringement opinions; and enforcement and litigation. Dr. Villacorta is chair of the firm’s Washington, D.C. office Intellectual Property Department.
CEO, SouthWest NanoTechnologies Inc. (SWeNT)
David Arthur has more than 30 years’ experience commercializing products utilizing advanced materials, including work at Rogers Corporation, A.T. Cross Company, TPI Composites, Helix Technologies, and Eikos. He holds a B.S.in chemical engineering from Tufts University, an M.S. in chemical engineering from the University of Connecticut and an MBA from Northeastern University. In 2005, Arthur co-founded Chasm Technologies, a consulting firm that helps its clients commercialize new products through smart application of materials science and process technology.
Chairman and Chief Executive Officer of Livingston Securities LLC.
Scott Livingston has been working on emerging technologies at Wall Street firms for 25 years and has specialized in nanotechnologies since 2002. Mr. Livingston has been called “sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been a keynote speaker on advanced technology investment trends in more than 30 states across America, including at MIT, the National Renewable Energy Lab (NREL), Brookhaven National Labs, Rice University Center for Nanotechnology, the Lawrence Berkeley Labs, Albany Nanotech, the President’s National Economic Council, numerous US congressional committees. In addition, the “Livingston Nanotechnology Conference,” is Wall Street’s largest and longest running annual nanotechnology investorconference, now in its 10th year.
Anil R. Diwan, Ph.D.
President and Chairman, NanoViricides, Inc.
Dr. Diwan invented novel polymeric micelle-based nanomedicine technologies as early as 1991. Dr. Diwan is a prolific inventor and a serial entrepreneur. Prior to co-founding NanoViricides, Inc., he has founded TheraCour Pharma, Inc., a privately held company focused in nanomedicines and cell-targeted drug delivery, and AllExcel, Inc., a company with diverse portfolios including nanomedicines, small chemicals, device technologies, as well as informatics. He has won several NIH SBIR (small business innovation research) grant awards.Â Anil holds a Ph.D. from Rice University, TX, a B.Tech. from Indian Institute of Technology, Mumbai (IIT-B), India, and has consistently held high scholastic ranks and honors. Dr. Diwan has over 25 years of Bio-Pharmaceutical R&D experience with over 20 years as an entrepreneur.
Gregory D. Cooper, Ph.D.
Founder & CTO, Pixelligent Technologies, LLC
Gregory D. Cooper, Ph.D., Founder and CTO. He founded the company in September 2000 shortly after receiving his Ph.D. in Physics from the University of Maryland. Dr. Cooper is recognized as an expert in nanocomposites—specifically, the relationship between material properties and system performance in mission-critical applications. He is primarily responsible for recruiting and managing the research and development teams, developing the intellectual property strategy, and contributing to overall business initiatives. Under his leadership, Pixelligent has been awarded more than $2.7 million in US government grants, raised more than $3 million in equity financing, and named a Maryland Incubator Company of the year. Dr. Cooper has authored and co-authored nine issued and six pending patents. He has been an invited speaker/presenter at Semicon West, 3 Beams conference, APS, and Nanotech Europe 2009.
Carleton Hsia, Ph.D
Chairman & CEO of SynZyme Technologies LLC and NanoBlood LLC
A distinguished research scientist and former university professor, Dr. Carleton J. C. Hsia is the Chairman& CEO of SynZyme Technologies LLC and NanoBlood LLC, both Biotech Companies are based in California. Dr. Hsia received his Ph.D. degree in Biochemistry and Biophysics from the University of Hawaii and was a Professor of Pharmacology and Biochemistry at the University of Toronto, School of Medicine. He was founder and Vice President of Research & Development for Hemosol, Inc. a New York and Toronto publicly traded company focused on developing a first generation blood substitute. Dr. Hsia holds 12 U.S. and international patents. He is active in the development of Nano Red Blood Cell (nRBC) for orphan indications such as sickle cell disease and traumatic brain injury complicated by hypotension. He is also actively developing nRBC for the treatment of stroke within and beyond the golden hour as well as treatment and prevention of neurological diseases such as Parkinson’s Disease. Treatments of eye diseases with nRBC are also being actively developed.
CEO, UltraTech International, Inc.
Mark Shaw has thirty years of experience in the designing, developing, sales and marketing of environmental products in the fields of spill containment, spill response, stormwater management, construction compliance, facility protection,bio-remediation (microbes), oil spill, radioactive waste management and nanotechnologies. Founded and operated four businesses servicing the environmental, industrial and safety market. Inventor or co-inventor of over sixty patents. Developed over 500 new products. Numerous new product of the year awards, three times named one of the fastest growing companies in NE Florida and Best Place to Work in NE Florida 2010. Founder and Principal in UltraTech International Inc. and Interpak, Inc. Credited with starting the Spill Containment Industry in the early 1980s. Extensive international business experience covering thirty countries. Numerous published articles, speeches and papers. TED Speaker, Long Beach 2013.
President, CEO and director of mPhase Technologies, Inc.
Ronald Durando currently serves as president, chief executive officer, and director of mPhase Technologies, Inc. Ronald Durando has extensive experience in corporate finance and manufacturing.
mPhase Technologies, a publicly traded company under the symbol XDSL based out of Norwalk, Connecticut, recently launched the mPower Jump It, a 12-volt jump starter. The innovative device is able to generate enough power to jump-start any four, six, or eight cylinder vehicle, yet remains extremely compact. In fact, the mPower Jump It is small enough to fit inside the average glove box. The product has been launched by mPower Technologies, Inc the consumer product division of mPhase Technologies. The mPower Jump It comes on the heels of the mPhase Smart NanoBattery, an innovative battery still in development at mPhase Technologies receiving the Frost and Sullivan 2013 North American Advanced Battery Technology Innovation Award.
Director of Government Programs of Brewer Science
Doyle Edwards has over 25 years experience in marketing and business development for companies ranging from small start-ups to Fortune 500 corporations. He is a graduate of the University of Central Missouri and continues to promote entrepreneurship and business development as an adjunct professor of marketing and business strategy. Mr. Edwards has been with Brewer Science since 2002 and is the director of government programs where he engages industry, business, and government organizations in support of developing nano and leading-edge technologies. His work includes active roles with key industry partners, including SEMI, Mercy Medical, Nanotechnology Enterprise Consortium, Tech 44, and the Jordan Valley Innovation Center. Brewer Science, headquartered in Rolla, Missouri, is a global leader in developing and manufacturing advanced materials, processes, devices and equipment for cutting-edge microdevices used in electronics such as sensors, tablet computers, smartphones, digital cameras, televisions, and LED lighting.
Chuck Van Fleet
President, Swan Chemical Inc, the Americas
I have been President of Swan Chemical Inc. (SCI) since 1997. Swan Chemical Inc. is a wholly owned subsidiary of Thomas Swan & Company Ltd, with headquarters in Lyndhurst, New Jersey and responsibility for activities in the Americas.
I head up key Swan activities in the rubber, coatings, printing ink, personal care and other performance chemical sectors in the region, as well as advanced applications for nanomaterial technologies. Our carbon nanotubes business has now achieved commercial scale production to meet growing demand in the USA. We have been working with US industry and governmental agencies and contractors on a range of groundbreaking nanomaterial development projects in advanced composites.
CEO Nanotronics Imaging
Matthew has a Ph.D. in Applied Physics. He is now a Professor and Researcher at Columbia University. He was an owner and Vice President of Development for Tech Pro, Inc., which was acquired by Roper Industries in March of 2008. During his time at Tech Pro, Matthew led two acquisitions, and the transformation of the instrument manufacturer into new global markets, having formed partnerships or subsidiaries in 15 nations. Matthew holds 5 patents, and has published over 20 technical papers, and in 2002 he won the ACS Best Paper Award. In addition to Columbia, Matthew has lectured at The University of Paris, USC, University of Michigan, and The Technical University of Sao Paulo.
Matthew has also produced several plays and films, and is an accomplished composer. He is a founding member of the World Science Festival. He is on the Executive Board of the Montauk Observatory, and is an Artist in Residence for Imagine Science Films.
Philip H. Lippel, PhD
Assistant Director, MIT Washington Office
Philip H. Lippel joined the MIT Washington Office in April 2012 as Assistant Director. He represents the Institute’s research enterprise and educational mission to the Department of Energy, the National Science Foundation, the Department of Education, the National Institute of Standards and Technology, and relevant Congressional committees. He also participates in inter-university government affairs forums through the American Association of Universities and the Association of Public and Land Grant Universities. He is interested in the multifaceted role research universities like MIT play in the innovation ecosystem — educating tomorrow’s workforce, driving discoveries at the leading edge of science and engineering, and working with industry to transition emerging technologies to commercial scale.
Sam Brauer, PhD
Principal, Nanobiz LLC
Samuel Brauer, Ph.D. has been with Nanobiz since its inception. He has worked on Nanobiz projects in areas such as coatings, filtration, photovoltaics, fuel cells, batteries and personal care. He has an extensive background in market research and an ability to estimate market sizes in widely diverse industries. This broad knowledge base is very useful when a cross-disciplinary approach is required to solve a knotty problem.
He is also the founder of Nanotech Plus, LLC an alliance of consultants focused on the business of nanotechnology offering analysis of this burgeoning field to major corporations, small materials companies, venture and angel investors, and other financial institutions. Established in 2004, the firms’ projects ranged from evaluating patent portfolios to estimating markets for novel therapeutics. Based on our findings, corporations have been able to develop new research directions in energy, filtration, and pharmaceuticals.
Lynn L. Bergeson
Managing Partner, Bergeson & Campbell PC
Owner of Bergeson & Campbell, P.C. (B&C®), Ms. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, biotechnology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether advocating before Congress, the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), or other governance and standard-setting bodies.
Ms. Bergeson counsels corporations, trade associations, and business consortia on a wide range of issues pertaining to chemical hazard, exposure and risk assessment, risk communication, minimizing legal liability, and evolving regulatory and policy matters pertinent to products of conventional, biotechnology, biobased chemicals, nanotechnologies, and other emerging technologies, particularly with respect to TSCA, FIFRA, Food Quality Protection Act (FQPA), REACH and REACH-like programs, and Occupational Safety and Health Administration (OSHA) matters.
Chairman of the Board, CEO & Managing Director, Harris & Harris Group, Inc.
Mr. Jamison has served as Chairman and Chief Executive Officer since January 2009; as President and Chief Operating Officer from January 2005 to December 2008; as Treasurer from March 2005 to May 2008; as a Managing Director since January 2004; as Chief Financial Officer from January 2005 to December 2007; and as Vice President from September 2002 to December 2004. He has been a member of our Board of Directors since May 2007. Since January 2009, he has served as Chairman and Chief Executive Officer of Harris & Harris Ventures Management, Inc., a wholly owned subsidiary of the Company, since 2005, he has served as a Director; and from January 2005 to December 2008, he served as President. From 1998 to 2002, Mr. Jamison worked as a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property for the University of Utah. This included assessing technologies in both the biological sciences and the physical sciences, working with patent attorneys to develop patent protection, and developing and marketing these technologies with industry. He is a Co-Editor-in-Chief, Journal of Nanotechnology Law & Business and Co-Chair of the Advisory Board, Converging Technology Bar Association. He was a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board. He was graduated from Dartmouth College (B.A.) and the University of Utah (M.S.).
Current Portfolio responsibilities: ABS Materials, HzO, Metabolon, Produced Water Absorbents, ProMuc, and Solazyme (NASDAQ:SZYM).
Chief Operating Officer, agencyIP
John Bender joined agencyIP in January, 2014, as Chief Operating Officer. Previously, Bender served as SVP, Operations and Supply Chain at Nanosolar, a clean-tech provider of utility-scale solar solutions. Among other duties, he managed the strategy, implementation, and later monetization of Nanosolar’s extensive IP portfolio comprised of technology awarded “#1 Innovation of the Year 2007” by Popular Science, and “Best Invention of the Year 2008,” by Time Magazine. Prior to joining Nanosolar, Bender served for more than 15 years at Hewlett-Packard Company in a wide variety of cross-functional leadership & executive roles including VP, Corporate Strategy & Technology, and leadership positions in HP’s Mergers & Acquisitions, R&D, product development, manufacturing, and supply chain functions. A noted M&A expert with more than 15 acquisitions to his credit, Bender is widely recognized for his key role leading Hewlett’s $19.5 billion acquisition of Compaq Computer. Bender holds a bachelor’s degree in Mechanical Engineering from Case Western Reserve University, and is a graduate of Harvard Business School. Teams under Bender’s leadership have been awarded more than 30 design patents, and he speaks regularly at industry conferences and universities.
Managing Director, National Nanomanufacturing Network
Jeff Morse is the Managing Director of the National Nanomanufacturing Network, a new organization sponsored by the National Science Foundation and coordinated through the Center for Hierarchical Manufacturing, at the University of Massachusetts, Amherst. Previously, Jeff has been a Senior Scientist in the Center for Micro and Nano Technology at Lawrence Livermore National Laboratory since 1985. He received his BS (1983) and MS (1985) Degrees in Electrical Engineering from the University of Massachusetts at Amherst, and a PhD (1992) in Electrical Engineering from Stanford University. His interests and expertise includes semiconductor devices and physics, advanced micro/nanofabrication processes, microelectromechanical systems (MEMS), microfluidics, catalytic microreactors, and micro-fuel cells. Jeff’s work has appeared in 15 journal publications, 45 conference presentations, with an additional 30 invited lectures at academic departments, industry research centers and technical meetings. Jeff additionally holds 15 patents in several technical areas.
Assistant Director for Nanotechnology at the White House Office of Science and Technology (OSTP)
Dr. Whitman is the Assistant Director for Nanotechnology at the White House Office of Science and Technology (OSTP), where he oversees the National Nanotechnology Initiative, the Materials Genome Initiative, and the intersection of these initiatives with advanced manufacturing. He also advises OSTP on issues related to federal agency participation in the development of and use of standards. Lloyd is on detail to OSTP from NIST, where since 2008 he has been the Deputy Director of the NIST Center for Nanoscale Science and Technology, the Department of Commerce’s nanotechnology user facility. Prior to joining OSTP, Lloyd served for nine months as the Interim Director of the National Nanotechnology Coordination Office. Lloyd received a B.S. in Physics from Brown University, and M.S. and Ph.D. degrees in Physics from Cornell University. He spent most of his research career at the Naval Research Laboratory, where he led an award-winning portfolio of research studying semiconductor, organic, and biomolecular nanostructures, their use in novel functional surfaces, and their integration into advanced sensor systems. Lloyd has over 160 publications and multiple patents in the areas of nanoscience and sensor technology, and has been recognized with numerous media citations and awards.
Director of Strategic Projects and Sustainability at the National Center for Manufacturing Sciences (NCMS)
Dr. Manish Mehta is Director of Strategic Projects and Sustainability at the National Center for Manufacturing Sciences (NCMS), the nation’s largest cross-industry R&D consortium based in Ann Arbor, Michigan, USA. His responsibilities include identifying new manufacturing technology needs, conducting emerging technology and business assessments, and managing collaborative projects and public-private ventures in lightweight materials, net shape manufacturing, nanomanufacturing, sustainability, and alternative energy. Previously, he was Manager of Consortium Programs at Environmental Research Institute of Michigan (1991-2000), and Principal Technical Fellow at Altarum Institute. Manish obtained his B.S. degree in Mechanical Engineering from Bangalore University (India), M.S. and Ph.D. degrees in Industrial Engineering from the University of Cincinnati. He completed the University of Michigan Ross Business School’s Executive Program in 2001, specializing in technology management and corporate strategy. He has a twenty-year history of organizing and managing collaborative OEM-supplier-academia-national lab projects in lightweight materials for the US Council for Automotive Research and the US Automotive Materials Partnership (USAMP).
Dr. Ajay P. Malshe
Founder & Chief Technology Officer (CTO; EVP)
Dr. Ajay P. Malshe (PhD. 1992) is a leading pioneer in the Nanomanufacturing field and the science of Convergent Assembly of Nanomaterials for real world breakthrough engineering applications.
Ajay is the Founder and Chief Technology Officer (CTO; EVP) of NanoMech Inc. (www.nanomech.com; founded in 2002). NanoMech Inc. is a Materials Science company equipped with a Nanomanufacturing factory enabling four divisions to introduce an array of products. NanoMech associates represent the best of the best scientists and engineers who ThinkSmall™ to deliver world-class product innovations. NanoMech values People, Ideas and Tools, respectively, for enhancing quality-of-life in a sustainable manner, using these nanotech product innovations.